Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · regulatory

China expands export controls on drug precursors ahead of Trump-Xi meeting

23 September 2026 · By · Wire by Fusion42

Published

23 September 2026

Topic

regulatory

◆ Sectors

Chemical

◆ Geography

China

◆ Source

Read at nbcnews.com →

◆ Verified

Fusion42 · 23 September 2026 · Fusion42 review

China has expanded its export controls by requiring permits for two additional drug precursor chemicals shipped to the United States, Canada, and Mexico, increasing the total controlled chemicals to 18.

This Wire brief sits within Fusion42's coverage of Chemical, and 10 sources have reported it between 17 Sep 2026 and 23 Sep 2026.

◆ ◆ The Wire takeaway

You face tighter export restrictions from China on precursors used in drug manufacturing, which could disrupt supply chains or require new compliance setups this week. Start identifying alternative suppliers or adjusting contracts to avoid shipment delays.

◆ Coverage

10 sources · first reported 17 Sep 2026 · latest 23 Sep 2026

◆ Related on Wire

◆ Topics

Chemicalchinaexport-controlsdrug-precursorsustrade-restrictions